Virological efficacy of dual therapy with lamivudine and dolutegravir in HIV-1-infected virologically suppressed patients: long-term data from clinical practice

J Antimicrob Chemother. 2019 May 1;74(5):1461-1463. doi: 10.1093/jac/dkz009.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-HIV Agents*
  • HIV-1*
  • Heterocyclic Compounds, 3-Ring
  • Lamivudine
  • Oxazines
  • Piperazines
  • Pyridones

Substances

  • Anti-HIV Agents
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • Lamivudine
  • dolutegravir